Anti-Human LDLRAD4 Polyclonal Antibody|抗人LDLRAD4多克隆抗体(靶标：人低密度脂蛋白受体A类结构域含蛋白4)
- 货号：RB9THD518014
- 价格：面议
- 点击：744
产品介绍
产品参数
| 形态 | Liquid |
|---|---|
| 宿主种属 | Rabbit |
| 克隆性 | Polyclonal |
| 抗体亚型 | IgG |
| 纯化方式 | Purified by antigen affinity column. |
| 内毒素水平 | Please contact with the lab for this information. |
| 应用 | ELISA, IHC, WB |
| 种属反应性 | Human |
| 靶标 | C18orf1, LDLRAD4, Low-density lipoprotein receptor class A domain-containing protein 4 |
| 免疫原 | E. coli - derived recombinant Human LDLRAD4 (Leu86-Val306). |
| 储存缓冲液 | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. |
| 产品使用说明 | ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000 |
| 登录号 | O15165 |
| 背景信息 | Low-density lipoprotein receptor class A domain-containing protein 4 (LDLRAD4) is a ~33 kDa protein. Functions as a negative regulator of TGF-beta signaling and thereby probably plays a role in cell proliferation, differentiation, apoptosis, motility, extracellular matrix production and immunosuppression. In the canonical TGF-beta pathway, ZFYVE9/SARA recruits the intracellular signal transducer and transcriptional modulators SMAD2 and SMAD3 to the TGF-beta receptor. Phosphorylated by the receptor, SMAD2 and SMAD3 then form a heteromeric complex with SMAD4 that translocates to the nucleus to regulate transcription. Through interaction with SMAD2 and SMAD3, LDLRAD4 may compete with ZFYVE9 and SMAD4 and prevent propagation of the intracellular signal. |
| 备注 | For research use only |
相关产品:
